Loop Capital analyst Joseph France lowered the firm’s price target on Cigna to $320 from $350 and keeps a Hold rating on the shares. The company’s enrollment finished strong in 2022, and it is off to an even faster start in 2023, but the firm’s price target is being cut to reflect the group’s recent weakness, the analyst tells investors in a research note. The firm adds that while Cigna is adding attractive new markets, it prefers names with larger and more diversified benefits businesses.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CI:
- Cigna sees FY23 adjusted EPS $24.60, consensus $24.84
- Cigna Reports Strong Fourth Quarter and Full Year 2022 Results, Establishes 2023 Guidance and Increases Dividend
- Cigna reports Q4 adjusted EPS $4.96, consensus $4.86
- Notable companies reporting before tomorrow’s open
- Managed care stocks pressured after CMS’ preliminary Medicare Advantage rates